NanoViricides, Inc. (NNVC) financial statements and ratios from SEC XBRL: revenue $0.00 (TTM). Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $0.00 |
| Price / Book | 3.13 |
| FCF Yield | -62.4% |
| Altman Z-Score | -16.55 (distress) |
| Sector P/E (Healthcare) | 21.7 |
NNVC overview · NNVC earnings · NNVC KPIs · NNVC investor relations · NNVC ownership · NNVC peers · NNVC filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.